Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology

How Common Is Hemicrania Continua? Age and Sex Patterns

At a Glance

Hemicrania continua is a very rare headache disorder. Studies report it more often in women, while most available data describe adults evaluated in specialist clinics at an average age of about 37 to 52 years. Age and recorded sex cannot confirm or rule out the diagnosis.

Hemicrania continua is a very rare headache disorder [1]. It is characterized by persistent, strictly one-sided head pain with severe exacerbations, along with other symptoms. Because it is so rare, demographic patterns can provide helpful context for researchers, but a person’s age or recorded sex cannot confirm or rule out the condition.

How Rare is Hemicrania Continua?

Studying exactly how many people have a rare condition is difficult. Different studies use different methods and timeframes, which means their estimates cannot be directly combined into a single range. The most robust recent studies provide estimates of its prevalence (the number of people who have the condition during a specific time):

Study Source & Location Population Studied Timeframe Estimated Frequency Key Limitation
Nationwide Study (Norway) [1] 4.3 million adults 1-year period 2.2 per 100,000 adults Based on diagnostic and prescription codes, which may miss undiagnosed patients.
Electronic Health Records (US) [2] National medical records platform 5-year period 7.2 per 100,000 people Based on diagnosed cases over a 5-year window; not directly comparable to a 1-year estimate.
Tertiary Headache Clinics (Global) [3] 9,854 adults evaluated for headache Point in time (varies) 1.8% of patients evaluated Represents only people referred to specialist centers, not the general public.

Currently, large population studies have not provided a well-established estimate for the incidence of hemicrania continua (the rate of newly diagnosed cases per year) [1][2].

If you are being treated at a tertiary headache clinic (a specialist center for complex or difficult-to-treat headaches), the condition might seem more common. However, the high frequency seen in specialty clinics reflects a highly selected group of patients, rather than the general public [3][4].

Who is Most Affected?

Sex Recorded in Studies

Hemicrania continua affects women more frequently than men [1][2]. In specialized clinical samples, researchers report a female-to-male ratio ranging between roughly 3-to-1 and 4.5-to-1 [5][6]. However, these ratios come from selected clinic populations and may not perfectly represent everyone with the condition.

Age of Onset

The exact age when the headaches first begin is not clearly established by large population studies [7]. Most research records a patient’s age when they are evaluated in a specialist clinic, which averages between 37 and 52 years old [7][5]. While primarily diagnosed in adults, it can occasionally occur in children, though pediatric cases are exceptionally rare [8].

Why is the Data Limited?

Getting exact numbers is challenging due to several overlapping issues:

  • Diagnostic Delays: Because the condition is rare, many patients go years without an accurate diagnosis. In some small clinical samples, the average delay from symptom onset to diagnosis was reported to be roughly 8 years [9].
  • Misdiagnosis: The persistent, mild background pain is sometimes overlooked by doctors, while the severe pain spikes can be mistaken for migraines or cluster headaches [9]. Exacerbations often include migraine-like features or autonomic symptoms (like same-side eye watering or nasal congestion), adding to the confusion [9].
  • Strict Diagnostic Criteria: The official diagnostic criteria (the specific symptom features clinicians use to make a diagnosis) require an “absolute” (complete) response to a medication called indomethacin [10]. However, indomethacin testing protocols vary. Different clinics use different doses, which can affect who receives an official diagnosis [10][11].
  • Evolving Definitions: The medical criteria used to define hemicrania continua have changed several times over the decades, making it harder for researchers to compare older studies with newer ones [9][3].

Important Note on Indomethacin and Safety

An “absolute” response to indomethacin is just one part of a broader clinical assessment [10]. It must be considered alongside your specific headache pattern and the exclusion of other conditions. A negative trial could simply mean the dose was too low, the duration too short, or that a different condition is present.

Never start, borrow, or adjust the dose of indomethacin without direct medical supervision. Indomethacin is a potent prescription anti-inflammatory drug that carries serious risks, including gastrointestinal ulcers and bleeding, kidney injury, blood pressure elevation, and cardiovascular complications. Your doctor will carefully monitor your trial and may prescribe a second medication to protect your stomach lining.

Red Flags: When to Seek Urgent Care

Hemicrania continua is typically a primary headache disorder, but persistent one-sided pain can also be a secondary headache (meaning the headache is caused by another underlying medical condition, like a vascular issue or structural lesion) [12][13].

You should seek urgent or emergency medical evaluation if you experience any “red flag” symptoms, such as:

  • A sudden, severe “worst-ever” headache
  • Rapidly worsening pain or a change in your usual headache pattern
  • New neurological symptoms (like weakness, numbness, or vision loss)
  • Confusion, fever, or neck stiffness
  • A new headache following a head injury
  • A new headache during pregnancy or postpartum

While demographic data can help researchers understand the disease on a population level, it should never be used to dismiss your symptoms. If you have a persistent, strictly one-sided headache with exacerbations, your symptoms warrant a professional assessment regardless of your age or sex.

Common questions in this guide

How rare is hemicrania continua?
Hemicrania continua is very rare, but estimates differ by study. A Norwegian population study estimated 2.2 cases per 100,000 adults in one year, while a U.S. records study found 7.2 per 100,000 people over five years; these figures are not directly comparable. In specialist headache clinics, it accounted for about 1.8% of evaluated headache patients, a selected group rather than the general public.
Does hemicrania continua affect women more often than men?
Yes, studies report it more often in women than in men. Selected specialist-clinic studies have found roughly three to four and a half women for every man. These ratios may not represent the general population, and recorded sex cannot confirm or exclude the diagnosis.
What age group is most often diagnosed with hemicrania continua?
The typical age when symptoms begin is not firmly established because studies often record age at specialist evaluation rather than true onset. Most reported patients are adults, and clinic studies describe an average evaluation age of about 37 to 52 years. The condition can occur in children, but pediatric cases are exceptionally rare.
Why is hemicrania continua often diagnosed years after symptoms start?
Because the disorder is rare, the continuous background pain may be overlooked and severe flares may be mistaken for migraine or cluster headache. Diagnostic criteria have changed over time, and clinics use different indomethacin testing protocols. These factors can contribute to delayed or missed diagnosis.
Can my age or sex rule out hemicrania continua?
No. Age and recorded sex describe patterns in groups of patients, but they cannot confirm or exclude hemicrania continua in one person. A persistent, strictly one-sided headache with severe flares should be assessed by a healthcare professional regardless of age or sex.
Does a response to indomethacin prove I have hemicrania continua?
No. A complete response to indomethacin is one part of the diagnostic criteria, but clinicians must also assess the headache pattern and rule out other conditions. An indomethacin trial should be prescribed and monitored by a clinician because the medicine can cause ulcers or bleeding, kidney injury, higher blood pressure, and cardiovascular complications.
When should a persistent one-sided headache be treated as an emergency?
Seek urgent or emergency evaluation for a sudden worst-ever headache, rapidly worsening pain or a major change in pattern, new weakness, numbness or vision loss, confusion, fever or neck stiffness, a headache after head injury, or a new headache during pregnancy or after delivery. Persistent one-sided pain also deserves medical assessment because it can sometimes be caused by another underlying condition.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Hemicrania continua.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since hemicrania continua is rare, how many cases have you or this clinic treated, and what is your protocol for diagnosing it?
  2. 2.Are there other primary or secondary headache conditions more common in my demographic that we should rule out first?
  3. 3.If we decide to test for this condition using an indomethacin trial, what dose will you use, how long will it last, and what stomach protection will you prescribe?
  4. 4.Could my headaches be secondary to another underlying condition, and what imaging or specific tests do we need to safely exclude that possibility?

References

References (13)
  1. 1

    One-year prevalence of cluster headache, hemicrania continua, paroxysmal hemicrania and SUNCT in Norway: a population-based nationwide registry study.

    Hagen K

    The journal of headache and pain 2024; (25(1)):30 doi:10.1186/s10194-024-01738-x.

    PMID: 38443787
  2. 2

    Prevalence, demographics, comorbidities, and treatment patterns of patients with the trigeminal autonomic cephalalgias: a retrospective analysis of United States electronic health records.

    Moskatel LS, Ogunlaja O, Zhang N

    BMC neurology 2025; (25(1)):299 doi:10.1186/s12883-025-04314-1.

    PMID: 40691779
  3. 3

    Prevalence and clinical features of hemicrania continua in clinic-based studies: A systematic review and meta-analysis.

    Al-Khazali HM, Al-Khazali S, Iljazi A, et al.

    Cephalalgia : an international journal of headache 2023; (43(1)):3331024221131343 doi:10.1177/03331024221131343.

    PMID: 36588185
  4. 4

    Trigeminal autonomic cephalalgias presenting in a multidisciplinary tertiary orofacial pain clinic.

    Wei DY, Moreno-Ajona D, Renton T, Goadsby PJ

    The journal of headache and pain 2019; (20(1)):69 doi:10.1186/s10194-019-1019-7.

    PMID: 31185885
  5. 5

    Melatonin in hemicrania continua and paroxysmal hemicrania.

    Cheung SN, Oliveira R, Goadsby PJ

    Cephalalgia : an international journal of headache 2024; (44(3)):3331024231226196 doi:10.1177/03331024231226196.

    PMID: 38518183
  6. 6

    How effective is melatonin as a preventive treatment for hemicrania continua? A clinic-based study.

    Rozen TD

    Headache 2015; (55(3)):430-6 doi:10.1111/head.12489.

    PMID: 25711410
  7. 7

    Do paroxysmal hemicrania and hemicrania continua represent different headaches? A retrospective study.

    Paliwal VK, Uniyal R, Aneez A, Singh LS

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2019; (40(11)):2371-2376 doi:10.1007/s10072-019-03980-7.

    PMID: 31256266
  8. 8

    The spectrum of indomethacin-responsive headaches in children and adolescents.

    Myers KA, Barmherzig R, Raj NR, et al.

    Cephalalgia : an international journal of headache 2022; (42(8)):793-797 doi:10.1177/03331024221076483.

    PMID: 35302385
  9. 9

    Hemicrania continua: clinical review, diagnosis and management.

    Prakash S, Patel P

    Journal of pain research 2017; (10()):1493-1509 doi:10.2147/JPR.S128472.

    PMID: 28721092
  10. 10

    Hemicrania Continua: An Update.

    Al-Khazali HM, Christensen RH, Lambru G, et al.

    Current pain and headache reports 2023; (27(10)):543-550 doi:10.1007/s11916-023-01156-9.

    PMID: 37566220
  11. 11

    Indomethacin Responsive Headaches: Exhaustive Systematic Review with Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies.

    Bordini EC, Bordini CA, Woldeamanuel YW, Rapoport AM

    Headache 2016; (56(2)):422-35 doi:10.1111/head.12771.

    PMID: 26853085
  12. 12

    Hemicrania continua secondary to neurogenic paravertebral tumor- a case report.

    Kalladka M, Al-Azzawi O, Heir GM, et al.

    Scandinavian journal of pain 2022; (22(1)):204-209 doi:10.1515/sjpain-2021-0089.

    PMID: 34432971
  13. 13

    Carotid Cavernous Fistula Mimicking Hemicrania Continua: A Case Report.

    Arnold Fiebelkorn C, Lanzino G, Chen JJ, et al.

    Headache 2019; (59(8)):1365-1369 doi:10.1111/head.13566.

    PMID: 31166017

This page is for informational purposes only and does not constitute medical advice. It summarizes population patterns in hemicrania continua; a clinician should evaluate your symptoms and supervise any indomethacin trial.